|
advertisement
|
|
|
| Journal Articles Details
|
| Pharmacogenomics Journals |
| Nat Genet. 36(11 Suppl):S34-42 |
Will tomorrow's medicines work for everyone? |
Tate SK, Goldstein DB.
Department of Biology, University College London, Darwin Building, Gower Street, London, WC1E 6BT, UK. |
Publication Date: Wednesday, October 27, 2004
|
Click here to view MEDLINE citation |
|
More October, 2004 pharmacogenomics journal articles.- Jonathan K. C. Knowles discusses the impact of pharmacogenomics on market segmentation.
by Knowles JK.
Journal: Nat Rev Drug Discov. 3(10):822
- Microarrays in pharmacogenomics.
by Chen JJ.
Journal: J Biopharm Stat. 14(3):535-7
- Genetic approaches to solving common diseases.
by Abou-Sleiman PM, Healy DG, Wood NW.
Journal: J Neurol. 251(10):1169-72
- Pharmacogenomics and colorectal cancer.
by
Journal: Ann Oncol. 15(suppl_4):iv173-iv177
- Single nucleotide polymorphisms in the apolipoprotein B and low density lipoprotein receptor genes affect response to antihypertensive treatment.
by Liljedahl U, Lind L, Kurland L, Berglund L, Kahan T, Syvänen AC.
Journal: BMC Cardiovasc Disord. 09 2004;4(1):16
- Pharmacogenetics in the rheumatic diseases.
by Cronstein BN.
Journal: Ann Rheum Dis. 63 Suppl 2:ii25-ii27
- Genetic polymorphisms of cytochrome P450 2D6 (CYP2D6): clinical consequences, evolutionary aspects and functional diversity.
by Ingelman-Sundberg M.
Journal: Pharmacogenomics J. 10 2004;:
- Genetic testing in primary care.
by Burke W.
Journal: Annu Rev Genomics Hum Genet. 5:1-14
- Variable sensitivity of FLT3 activation loop mutations to the small molecule tyrosine kinase inhibitor MLN518.
by Clark JJ, Cools J, Curley DP, Yu JC, Lokker NA, Giese NA, Gilliland DG.
Journal: Blood. 104(9):2867-72
- Targeted therapies for cancer 2004.
by Ross JS, Schenkein DP, Pietrusko R, Rolfe M, Linette GP, Stec J, Stagliano NE, Ginsburg GS, Symmans WF, Pusztai L, Hortobagyi GN.
Journal: Am J Clin Pathol. 122(4):598-609
- Dopamine receptor DRD2 genotype and smoking cessation outcome following treatment with bupropion SR.
by Swan GE, Valdes AM, Ring HZ, Khroyan TV, Jack LM, Ton CC, Curry SJ, McAfee T.
Journal: Pharmacogenomics J. 10 2004;:
- [ASCO Annual Meeting 2004, New Orleans. Therapeutic options in colorectal cancer]
by Longo F, Mansueto G.
Journal: Tumori. 2004 Jul-Aug;90(4):13-27
- Pharmacogenetics of irinotecan toxicity.
by Marsh S, McLeod HL.
Journal: Pharmacogenomics. 5(7):835-43
- Pharmacogenomics of adrenoceptors.
by Flordellis C, Paris H, Karabinis A, Lymperopoulos A.
Journal: Pharmacogenomics. 5(7):803-17
- Optimized antiretroviral therapy: the role of therapeutic drug monitoring and pharmacogenomics.
by van Heeswijk RP.
Journal: Expert Rev Anti Infect Ther. 1(1):75-81
- Pharmacogenetics of methotrexate.
by Krajinovic M, Moghrabi A.
Journal: Pharmacogenomics. 5(7):819-34
- Association study of myo-inositol monophosphatase 2 (IMPA2) polymorphisms with bipolar affective disorder and response to lithium treatment.
by Dimitrova A, Milanova V, Krastev S, Nikolov I, Toncheva D, Owen MJ, Kirov G.
Journal: Pharmacogenomics J. 10 2004;:
- Renin-angiotensin system gene polymorphisms: relationship with blood pressure and microalbuminuria in telmisartan-treated hypertensive patients.
by Redon J, Luque-Otero M, Martell N, Chaves FJ.
Journal: Pharmacogenomics J. 10 2004;:
- Genetic determinants of platelet function in thromboembolic diseases.
by Corral J, González-Conejero R, Vicente V.
Journal: J Biol Regul Homeost Agents. 2004 Apr-Jun;18(2):166-71
More pharmacogenomics journal articles ... |
Journal Articles Categories:
Health Informatics Journal Articles |
Telemedicine Journal Articles |
Hospital Information Systems Journal Articles |
Data Protection and Privacy Journals Articles |
Mobile and Wireless Computing Journal Articles |
Medical Decision Making |
Bioinformatics Journal Articles |
Genomics Journal Articles |
Proteomics Journal Articles |
Pharmacogenomics Journal Articles
|